Literature DB >> 18607151

The metabolic syndrome and cardiovascular disease: Part I.

Panupong Jiamsripong1, Martina Mookadam, Tadaaki Honda, Bijoy K Khandheria, Farouk Mookadam.   

Abstract

The metabolic syndrome is a constellation of metabolic risk factors and physical conditions that are accompanied by an enhanced propensity toward the development of type 2 diabetes, atherosclerosis, and cardiovascular disease. It presents a combination of atherosclerosis risk including atherogenic dyslipidemia, hypertension, elevated plasma glucose, hypercoagulability, and a proinflammatory state. The 2 major underlying risk factors for the metabolic syndrome are obesity and insulin resistance. Exacerbating factors are physical inactivity, advancing age, and endocrine and genetic factors. Associated hyperinsulinemia, hyperglycemia, and elevated adipokine levels (adipose cytokines) lead to vascular endothelial dysfunction, an abnormal lipid profile, hypertension, and vascular inflammation, all of which promote the development of atherosclerotic cardiovascular disease. In this 2-part series, the authors present an up-to-date and detailed systematic review of the literature on this important topic.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18607151     DOI: 10.1111/j.1751-7141.2008.07809.x

Source DB:  PubMed          Journal:  Prev Cardiol        ISSN: 1520-037X


  8 in total

1.  Geometric influence of the sagittal and vertical apical base relationship on the ANB angle.

Authors:  Reza Sadat-Khonsari; Henning Dathe; Michael Knösel; Wolfram Hahn; Dietmar Kubein-Meesenburg; Oskar Bauss
Journal:  J Orofac Orthop       Date:  2009-03-26       Impact factor: 1.938

2.  Allometric prediction of the human pharmacokinetic parameters for naveglitazar.

Authors:  Preeti Ahlawat; Nuggehally R Srinivas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Jul-Sep       Impact factor: 2.441

3.  Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats.

Authors:  Ahmed A Elmarakby; John D Imig
Journal:  Clin Sci (Lond)       Date:  2010-02       Impact factor: 6.124

4.  The association between pre-pregnancy BMI and preterm delivery in a diverse southern California population of working women.

Authors:  Jessica Lang Kosa; Sylvia Guendelman; Michelle Pearl; Steve Graham; Barbara Abrams; Martin Kharrazi
Journal:  Matern Child Health J       Date:  2011-08

5.  The effect of pioglitazone on circulating interleukin-10 and tumor necrosis factor-alpha levels in a patient with metabolic syndrome: A randomized, double-blind controlled trial.

Authors:  Ali Pourmoghaddas; Mehrnaz Dormiani-Tabatabaei; Masoumeh Sadeghi; Mohammad Kermani-Alghoraishi; Jafar Golshahi; Pedram Shokouh
Journal:  ARYA Atheroscler       Date:  2015-01

6.  Sex-specific chronic stress response at the level of adrenal gland modified sexual hormone and leptin receptors.

Authors:  Marta Balog; Milan Miljanović; Senka Blažetić; Irena Labak; Vedrana Ivić; Barbara Viljetić; Attila Borbely; Zoltán Papp; Robert Blažeković; Sandor G Vari; Miklós Fagyas; Marija Heffer
Journal:  Croat Med J       Date:  2015-04       Impact factor: 1.351

7.  Circulating angiogenic stem cells in type 2 diabetes are associated with glycemic control and endothelial dysfunction.

Authors:  Nagma Zafar; Sathya S Krishnasamy; Jasmit Shah; Shesh N Rai; Daniel W Riggs; Aruni Bhatnagar; Timothy E O'Toole
Journal:  PLoS One       Date:  2018-10-15       Impact factor: 3.240

Review 8.  Effect of Intermittent Fasting Diet on Glucose and Lipid Metabolism and Insulin Resistance in Patients with Impaired Glucose and Lipid Metabolism: A Systematic Review and Meta-Analysis.

Authors:  Xiaojie Yuan; Jiping Wang; Shuo Yang; Mei Gao; Lingxia Cao; Xumei Li; Dongxu Hong; Suyan Tian; Chenglin Sun
Journal:  Int J Endocrinol       Date:  2022-03-24       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.